Torthaí cuardaigh - David N. Cook

  • 1 - 7 toradh as 7 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Molecular cloning and characterization of acrA and acrE genes of Escherichia coli

    Molecular cloning and characterization of acrA and acrE genes of Escherichia coli de réir D Ma, David N. Cook, Marie Alberti, Ning G. Pon, Hiroshi Nikaido, John E. Hearst

    Foilsithe / Cruthaithe 1993
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    <i>Listeria</i>-based cancer vaccines that segregate immunogenicity from toxicity

    <i>Listeria</i>-based cancer vaccines that segregate immunogenicity from toxicity de réir Dirk G. Brockstedt, Martin Giedlin, Meredith L. Leong, Keith S. Bahjat, Yi Qin Gao, William Luckett, Weiqun Liu, David N. Cook, Daniel A. Portnoy, Thomas W. Dubensky

    Foilsithe / Cruthaithe 2004
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent<i>Clostridium difficile</i>Infection

    A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent<i>Clostridium difficile</i>Infection de réir Sahil Khanna, Darrell S. Pardi, Colleen Kelly, Colleen S. Kraft, Tanvi Dhere, Matthew R. Henn, Mary-Jane Lombardo, Marin Vulić, Toshiro K. Ohsumi, Jonathan Winkler, Christina Pindar, Barbara McGovern, Roger J. Pomerantz, John Auniņš, David N. Cook, Elizabeth Hohmann

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Dosing a synbiotic of human milk oligosaccharides and B. infantis leads to reversible engraftment in healthy adult microbiomes without antibiotics

    Dosing a synbiotic of human milk oligosaccharides and B. infantis leads to reversible engraftment in healthy adult microbiomes without antibiotics de réir Julie E. Button, Chloe Autran, Abigail L. Reens, Casey M. Cosetta, Steven Smriga, M. Ericson, Jessica V. Pierce, David N. Cook, Martin L. Lee, Adam K. Sun, Amin M. Alousi, Andrew Y. Koh, David J. Rechtman, Robert R. Jenq, Gregory J. McKenzie

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity

    Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity de réir Dirk G. Brockstedt, Keith S. Bahjat, Martin Giedlin, Wei Liu, Mark K Leong, William Luckett, Yi Gao, Pamela Schnupf, Dilnawaz Kapadia, Grace Castro, Jie-Hui Lim, Adam Sampson-Johannes, Anat A. Herskovits, Adonis Stassinopoulos, H. G. Archie Bouwer, J Hearst, Daniel A. Portnoy, David N. Cook, Thomas W. Dubensky

    Foilsithe / Cruthaithe 2005
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    SER-109, an Investigational Microbiome Drug to Reduce Recurrence After <i>Clostridioides difficile</i> Infection: Lessons Learned From a Phase 2 Trial

    SER-109, an Investigational Microbiome Drug to Reduce Recurrence After <i>Clostridioides difficile</i> Infection: Lessons Learned From a Phase 2 Trial de réir Barbara McGovern, Christopher B. Ford, Matthew R. Henn, Darrell S. Pardi, Sahil Khanna, Elizabeth Hohmann, Edward J. O’Brien, Christopher A. Desjardins, Patricia Bernardo, Jennifer R. Wortman, Mary-Jane Lombardo, Kevin Litcofsky, Jonathan Winkler, Christopher McChalicher, Sunny S. Li, Amelia D. Tomlinson, Madhumitha Nandakumar, David N. Cook, Roger J. Pomerantz, John Auniņš, Michele Trucksis

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis

    A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis de réir Matthew R. Henn, Edward J. O’Brien, Liyang Diao, Brian G. Feagan, William J. Sandborn, Curtis Huttenhower, Jennifer R. Wortman, Barbara McGovern, Sherry Wang‐Weigand, David I. Lichter, Meghan Chafee, Christopher B. Ford, Patricia Bernardo, Peng Zhao, Sheri L. Simmons, Amelia D. Tomlinson, David N. Cook, Roger J. Pomerantz, Bharat Misra, John Auniņš, Michele Trucksis

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: